David A. Kekich
L. Stephen Coles
David A. Kekich
President & C.E.O
Mr. Kekich founded the country’s largest life insurance master general agency, co-founded a major financial services company and arranged venture capital funding for private companies. He is a recognized expert on private investing and authored the venture capital handbook “How the Rich Get Richer with Quiet Private Investments”.
Mr. Kekich founded both public and private companies, was engaged as a consultant and served as director to numerous private and public corporations. He also sold and developed real estate. In 1999, Mr. Kekich founded the “Maximum Life Foundation”, a 501(c)(3) corporation dedicated to curing aging related diseases.
L. Stephen Coles
(In Memoriam) Chief Scientific Officer
VP for Medical Education, The Kronos Group, is a Co-Founder and Director of the Los Angeles Gerontology Research Group. He is Assistant Researcher in the Department of Surgery at the UCLA Medical School. Dr. Coles is the author of over 70 scientific papers and holds two patents.
He received his B.S. in Electrical Engineering from Rensselaer Polytechnic Institute in Troy, New York, his Master's in Mathematics from the Carnegie Institute of Technology, and his Ph.D. in Systems and Communication Sciences from Carnegie-Mellon University in Pittsburgh, Pennsylvania. After attending Stanford University Medical School, Dr. Coles completed his Clinical Internship in OB/GYN at the Jackson Memorial Hospital of the University of Miami Medical School. After teaching at UC Berkeley, Dr. Coles served as a Visiting Scientist for the Central Intelligence Agency's Office of Research and Development in Washington, D.C.
Michael Riskin, PhD, CPA
In addition to many years of practice in public accounting and general business consulting, Dr. Riskin held the positions of Systems Engineer with IBM, and Manager of
National Accounts with Xerox Computer Systems. His responsibilities with IBM and Xerox focused on the development and installation of business and management systems and applications.
Since the early 1990's, he has been an international consultant and a CFO, based in Venezuela, Curacao, and most recently Costa Rica as well as Los Angeles and Phoenix. His industry specializations included biotechnology, telecommunications and banking/financial services.
A published author, and writer of a business advisory column entitled "Financially Speaking" for licensed California professionals, he has been on the faculty and taught business and human behavior courses at several institutions of higher learning in Southern California over the past twenty years.
Dr. Riskin has been licensed as a Certified Public Accountant in California since 1967, and holds a Doctorate in Psychology. His interest in longevity and life extension goes back several decades. Besides his involvement with Maximum Life Foundation, he is Chairman of the Board of Directors of Alcor Life Extension Foundation.
Bryant Villeponteau, Ph.D.
Vice President of Research
Dr. Villeponteau has 30 years of scientific leadership experience and about 60 scientific journal and patent publications. Dr. Villeponteau holds a B.A. in Economics, a M.A. in Biostatistics, and a Ph.D. in Molecular Biology from UCLA. He was Assistant Research Chemist in the Department of Chemistry and Biochemistry at UCLA for 4 years and Assistant Professor of Biological Chemistry at the University of Michigan Medical School for 6 years.
Dr. Villeponteau then led a research group at Geron Corporation for 4.5 years, where he was the lead inventor in cloning human telomerase, thereby winning the Distinguished Inventor Award for the 2nd best US patent of 1997. As the Champion of Telomerase Therapeutics at Geron, he also worked on human stem cells, which were pioneered by Geron in the 90s. Dr. Villeponteau then joined HealthSpan Sciences, Inc. as VP and later served as CEO for three years. For the next 8 years, he served as a VP/consultant for Sierra Sciences.
From September of 2008 to present, Dr. Villeponteau has been the VP of R & D of Genescient Corporation. Dr. Villeponteau also cofounded Centagen, incorporated in January of 2009, and Life Code LLC in October of 2010, which has marketed a successful supplement that doubles maximum lifespan in model animals and supports stem cells and their niches.